chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: nausea; a little achiness; fatigue; stomach upset; "hot circle" at the injection site; sore left arm; headache; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach upset), VACCINATION SITE WARMTH ("hot circle" at the injection site), PAIN IN EXTREMITY (sore left arm), NAUSEA (nausea) and MYALGIA (a little achiness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2020, Pharyngitis streptococcal, Ear infection, Bladder infection and Abdominal operation NOS. Concurrent medical conditions included Hypertension, IgG subclass deficiency, IgG subclass deficiency, Hypothyroidism, Allergic asthma, Occupational asthma, Fibromyalgia, Celiac disease, Interstitial lung disease (scar tissue narrowed airways), Egg allergy and Drug allergy (Allergic to Ceclor, cephalosporins, tetracycline, Demerol, ciprofloxacin, codeine, red dye #4, and macrodantin.). Concomitant products included QUINAPRIL, THYROID (ARMOUR THYROID), PROGESTERONE, IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), GUAIFENESIN and ALBUTEROL SULFATE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 26-Feb-2021, the patient experienced VACCINATION SITE WARMTH ("hot circle" at the injection site), PAIN IN EXTREMITY (sore left arm), HEADACHE (headache) and VACCINATION SITE PAIN (pain at the injection site). On 27-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach upset), NAUSEA (nausea), MYALGIA (a little achiness) and FATIGUE (fatigue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 26-Feb-2021 at an unspecified dose and frequency and IBUPROFEN on 26-Feb-2021 at an unspecified dose and frequency. On 01-Mar-2021, PAIN IN EXTREMITY (sore left arm) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (stomach upset), NAUSEA (nausea), MYALGIA (a little achiness), FATIGUE (fatigue), HEADACHE (headache) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown and VACCINATION SITE WARMTH ("hot circle" at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain, Vaccination site warmth
Clinical narrative: nausea; a little achiness; fatigue; stomach upset; "hot circle" at the injection site; sore left arm; headache; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach upset), VACCINATION SITE WARMTH ("hot circle" at the injection site), PAIN IN EXTREMITY (sore left arm), NAUSEA (nausea) and MYALGIA (a little achiness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2020, Pharyngitis streptococcal, Ear infection, Bladder infection and Abdominal operation NOS. Concurrent medical conditions included Hypertension, IgG subclass deficiency, IgG subclass deficiency, Hypothyroidism, Allergic asthma, Occupational asthma, Fibromyalgia, Celiac disease, Interstitial lung disease (scar tissue narrowed airways), Egg allergy and Drug allergy (Allergic to Ceclor, cephalosporins, tetracycline, Demerol, ciprofloxacin, codeine, red dye #4, and macrodantin.). Concomitant products included QUINAPRIL, THYROID (ARMOUR THYROID), PROGESTERONE, IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), GUAIFENESIN and ALBUTEROL SULFATE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 26-Feb-2021, the patient experienced VACCINATION SITE WARMTH ("hot circle" at the injection site), PAIN IN EXTREMITY (sore left arm), HEADACHE (headache) and VACCINATION SITE PAIN (pain at the injection site). On 27-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach upset), NAUSEA (nausea), MYALGIA (a little achiness) and FATIGUE (fatigue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 26-Feb-2021 at an unspecified dose and frequency and IBUPROFEN on 26-Feb-2021 at an unspecified dose and frequency. On 01-Mar-2021, PAIN IN EXTREMITY (sore left arm) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (stomach upset), NAUSEA (nausea), MYALGIA (a little achiness), FATIGUE (fatigue), HEADACHE (headache) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown and VACCINATION SITE WARMTH ("hot circle" at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Malaise, Nausea
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of chills, asthenia (weakness/fatigue), malaise (not feeling well) and nausea in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Feb 26, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced chills, asthenia (weakness/fatigue), malaise (not feeling well) and nausea. At the time of the report, chills, asthenia (weakness/fatigue), malaise (not feeling well) and nausea outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications or treatment information reported.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Chills, Fatigue, Headache
Clinical narrative: Arthritis due to the cold; headache; Joint pain; Chills; Tired, fatigue; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Arthritis due to the cold), HEADACHE (headache), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Tired, fatigue) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20/A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis (Medical history reported as arthritis), Joint pain (Medical history reported as joint pain) and Memory loss (Medical history reported as amnesia). Concomitant products included CHONDROITIN SULFATE, GLUCOSAMINE (MOVE FREE [CHONDROITIN SULFATE;GLUCOSAMINE]) for Arthritis and Joint pain, CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]) for Energy Levels, APOAEQUORIN (PREVAGEN [APOAEQUORIN]) for Memory loss.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced HEADACHE (headache), ARTHRALGIA (Joint pain), CHILLS (Chills), FATIGUE (Tired, fatigue) and MYALGIA (Muscle pain). On an unknown date, the patient experienced ARTHRITIS (Arthritis due to the cold). On 06-Feb-2021, HEADACHE (headache), CHILLS (Chills), FATIGUE (Tired, fatigue) and MYALGIA (Muscle pain) had resolved, ARTHRALGIA (Joint pain) outcome was unknown. At the time of the report, ARTHRITIS (Arthritis due to the cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Arthritis due to the cold; headache; Joint pain; Chills; Tired, fatigue; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Arthritis due to the cold), HEADACHE (headache), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Tired, fatigue) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20/A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis (Medical history reported as arthritis), Joint pain (Medical history reported as joint pain) and Memory loss (Medical history reported as amnesia). Concomitant products included CHONDROITIN SULFATE, GLUCOSAMINE (MOVE FREE [CHONDROITIN SULFATE;GLUCOSAMINE]) for Arthritis and Joint pain, CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]) for Energy Levels, APOAEQUORIN (PREVAGEN [APOAEQUORIN]) for Memory loss.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced HEADACHE (headache), ARTHRALGIA (Joint pain), CHILLS (Chills), FATIGUE (Tired, fatigue) and MYALGIA (Muscle pain). On an unknown date, the patient experienced ARTHRITIS (Arthritis due to the cold). On 06-Feb-2021, HEADACHE (headache), CHILLS (Chills), FATIGUE (Tired, fatigue) and MYALGIA (Muscle pain) had resolved, ARTHRALGIA (Joint pain) outcome was unknown. At the time of the report, ARTHRITIS (Arthritis due to the cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Gait inability, Pain in extremity
Clinical narrative: very dizzy; can't walk to much; Pain and tenderness arm; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (very dizzy), GAIT INABILITY (can't walk to much) and PAIN IN EXTREMITY (Pain and tenderness arm) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (very dizzy), GAIT INABILITY (can't walk to much) and PAIN IN EXTREMITY (Pain and tenderness arm). At the time of the report, DIZZINESS (very dizzy), GAIT INABILITY (can't walk to much) and PAIN IN EXTREMITY (Pain and tenderness arm) outcome was unknown.            This case was linked to MOD-2021-033870, MOD-2021-033870 (Patient Link).
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: high fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high fever) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 04-Mar-2021, the patient experienced PYREXIA (high fever). At the time of the report, PYREXIA (high fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Headache
Clinical narrative: Headache; Tiredness; Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), FATIGUE (Tiredness) and COVID-19 (Covid-19) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included Urinary tract infection. Concurrent medical conditions included Renal failure. Concomitant products included MULTIVITAMIN & MINERAL and METFORMIN for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced COVID-19 (Covid-19). On an unknown date, the patient experienced HEADACHE (Headache) and FATIGUE (Tiredness). At the time of the report, HEADACHE (Headache), FATIGUE (Tiredness) and COVID-19 (Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to (E2B Linked Report). This case was linked to; Sender's Comments:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Didn't feel good; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Didn't feel good) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Didn't feel good). At the time of the report, VACCINATION COMPLICATION (Didn't feel good) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included C-section (Live, Full time birth) on 02-Dec-2018. Concurrent medical conditions included Drug allergy (Monistat) and Gestational diabetes.    On 25-Feb-2021 at 7:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 14-Jul-2020 and the estimated date of delivery was 16-Apr-2021. On 25-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-second week of the pregnancy.  On 25-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment was provided. No concomitants were provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site erythema, Vaccination site swelling, Vomiting
Clinical narrative: Vomiting; Swelling at the injection site; Nausea; Redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), VOMITING (Vomiting), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling at the injection site) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FLUOXETINE for an unknown indication.    On 02-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site). On 02-Mar-2021 at 11:00 PM, the patient experienced NAUSEA (Nausea). On 03-Mar-2021, the patient experienced VOMITING (Vomiting). 03-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, NAUSEA (Nausea), VOMITING (Vomiting), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling
Clinical narrative: Aches and pain all over; Sore arn; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches and pain all over) and PERIPHERAL SWELLING (Sore arn) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN (Aches and pain all over) and PERIPHERAL SWELLING (Sore arn). At the time of the report, PAIN (Aches and pain all over) and PERIPHERAL SWELLING (Sore arn) outcome was unknown.            Concomitant medication also included cholesterol and blood pressure medications. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash in her face, neck and chest.; This spontaneous case was reported by a dental hygienist and describes the occurrence of RASH (Rash in her face, neck and chest.) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced RASH (Rash in her face, neck and chest.). At the time of the report, RASH (Rash in her face, neck and chest.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable. The patient reported that the rash went away as soon as it came.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Arm pretty sore; Skin got thicker in area of injection; Itching so bad in site of injection; Raise up in the area of the injection site; Tender around njection site, about size of a small orange, pink area; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pretty sore), VACCINATION SITE INDURATION (Skin got thicker in area of injection), VACCINATION SITE PRURITUS (Itching so bad in site of injection), VACCINATION SITE PAIN (Tender around njection site, about size of a small orange, pink area) and VACCINATION SITE SWELLING (Raise up in the area of the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L2OA) for COVID-19 vaccination.  Concurrent medical conditions included Blood pressure and Cholesterol.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pretty sore) and VACCINATION SITE PAIN (Tender around njection site, about size of a small orange, pink area). On 02-Mar-2021, the patient experienced VACCINATION SITE INDURATION (Skin got thicker in area of injection), VACCINATION SITE PRURITUS (Itching so bad in site of injection) and VACCINATION SITE SWELLING (Raise up in the area of the injection site). At the time of the report, PAIN IN EXTREMITY (Arm pretty sore), VACCINATION SITE INDURATION (Skin got thicker in area of injection), VACCINATION SITE PRURITUS (Itching so bad in site of injection), VACCINATION SITE PAIN (Tender around njection site, about size of a small orange, pink area) and VACCINATION SITE SWELLING (Raise up in the area of the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication list included blood pressure and cholesterol medication. Treatment information was not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes virus infection
Clinical narrative: Harpies general; This spontaneous case was reported by a consumer and describes the occurrence of HERPES VIRUS INFECTION (Harpies general) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included LOSARTAN, ATORVASTATIN CALCIUM (LIPITOR), VENLAFAXINE and ATORVASTATIN for an unknown indication.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced HERPES VIRUS INFECTION (Harpies general). At the time of the report, HERPES VIRUS INFECTION (Harpies general) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  It was mentioned that patient would like to take Acyclovir 400mg, not started yet.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Lacrimation increased, Tongue discomfort
Clinical narrative: her tongue kind of burnt; right side of the face being "nummy; eye was watering; This spontaneous case was reported by a nurse and describes the occurrence of TONGUE DISCOMFORT (her tongue kind of burnt), HYPOAESTHESIA (right side of the face being "nummy) and LACRIMATION INCREASED (eye was watering) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TONGUE DISCOMFORT (her tongue kind of burnt), HYPOAESTHESIA (right side of the face being "nummy) and LACRIMATION INCREASED (eye was watering). At the time of the report, TONGUE DISCOMFORT (her tongue kind of burnt), HYPOAESTHESIA (right side of the face being "nummy) and LACRIMATION INCREASED (eye was watering) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-089737 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Feb-2021: TCR: daughter is fine, no further follow up needed, had same events with second dose.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Vaccination site haemorrhage
Clinical narrative: after they pulled out the syringe some blood dripped down the patient's arm; patient was concern they did not get the full dose; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE HAEMORRHAGE (after they pulled out the syringe some blood dripped down the patient's arm) and INCORRECT DOSE ADMINISTERED (patient was concern they did not get the full dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (after they pulled out the syringe some blood dripped down the patient's arm) and INCORRECT DOSE ADMINISTERED (patient was concern they did not get the full dose). On 26-Feb-2021, VACCINATION SITE HAEMORRHAGE (after they pulled out the syringe some blood dripped down the patient's arm) had resolved. At the time of the report, INCORRECT DOSE ADMINISTERED (patient was concern they did not get the full dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications for the event was not provided.  No treatment information provided
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Myalgia, Pyrexia
Clinical narrative: Diarrhea; Fever; Headaches; Body aches; A spontaneous report was received from a healthcare professional concerning a 52-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever, headache, body ache/myalgia, diarrhea.  The patient's medical history was not provided. Concomitant medications reported included histamine, zincoxide, aluminum hydroxide, apixaban, ondansetron, hydroxychloroquine sulphate, lithium, prednisone, nalidixic acid, omeprazole, cimetidine, montelukast sodium, albuterol, diphenhydramine hydrochloride, sertraline, ipratropium bromide-albuterol, adalimumab, pregabalin, hydralazine, roquinimex, fluticasone furoate, potassium, tizanidine products used for unknown indication.  On 24 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) via unknown route and site for prophylaxis of COVID-19 infection.   On 24 Feb 2021, the patient experienced the events, fever, headache, body ache/myalgia, diarrhea . Treatment for the events included paracetamol. Body temperature was 100-101.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events fever, headache, body ache/myalgia, diarrhea, were considered not resolved.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: a travelling pain throughout their body; chills; mild nausea; headache; fever of 100.9; fatigue; A spontaneous report was received from a health care professional concerning a 78-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chills, mild nausea, headache, fever (100.9), fatigue and a travelling pain throughout the body.   The patient's medical history, was not provided by the reporter. Concomitant medications reported included dopacin, atorvastatin, low dose and pensolosin.  On 02 Mar 2021, the patient received their second of two planned doses of mRNA-1273 (Lot number: Unknown) for prophylaxis of COVID-19 infection.   On 02 Mar 2021, after 4 or 5 hours later the patient experienced chills,  mild nausea, headache, fever (100.9), fatigue and a travelling pain throughout the body.    Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events, chills, mild nausea, headache, fever (100.9), fatigue and a travelling pain throughout the body is unknown
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: a travelling pain throughout their body; chills; mild nausea; headache; fever of 100.9; fatigue; A spontaneous report was received from a health care professional concerning a 78-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chills, mild nausea, headache, fever (100.9), fatigue and a travelling pain throughout the body.   The patient's medical history, was not provided by the reporter. Concomitant medications reported included dopacin, atorvastatin, low dose and pensolosin.  On 02 Mar 2021, the patient received their second of two planned doses of mRNA-1273 (Lot number: Unknown) for prophylaxis of COVID-19 infection.   On 02 Mar 2021, after 4 or 5 hours later the patient experienced chills,  mild nausea, headache, fever (100.9), fatigue and a travelling pain throughout the body.    Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events, chills, mild nausea, headache, fever (100.9), fatigue and a travelling pain throughout the body is unknown
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Pain, Pyrexia
Clinical narrative: chills; fever; body soreness; headache; feels like a truck is sitting on top of me; still feel weak; runny nose; A spontaneous report was received from a consumer, concerning a female patient of 74 years, who received Moderna's COVID-19 vaccine and experienced chills, fever, body soreness, runny nose,and headaches,awful feeling,feel weak,feels like a truck is sitting on top of me.  The patient's medical history was covid-19 in mar-2020. Concomitant product use was Zocor, Ambien,Premarin by the reporter.  On an 01-mar-2021, prior to the onset of events, the patient received their first of two planned dose of mRNA-1273 (lot number 010A21A ) via intramuscular route for COVID-19 infection prophylaxis.  On an 2-mar-2021, after first dose of vaccine, the patient experienced ongoing chills, fever, body soreness, runny nose,and headaches,awful feeling,feel weak,feels like a truck is sitting on top of me. No treatment medication was reported.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the events was considered to be unknown at the time of this report.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: chills; fever; body soreness; headache; feels like a truck is sitting on top of me; still feel weak; runny nose; A spontaneous report was received from a consumer, concerning a female patient of 74 years, who received Moderna's COVID-19 vaccine and experienced chills, fever, body soreness, runny nose,and headaches,awful feeling,feel weak,feels like a truck is sitting on top of me.  The patient's medical history was covid-19 in mar-2020. Concomitant product use was Zocor, Ambien,Premarin by the reporter.  On an 01-mar-2021, prior to the onset of events, the patient received their first of two planned dose of mRNA-1273 (lot number 010A21A ) via intramuscular route for COVID-19 infection prophylaxis.  On an 2-mar-2021, after first dose of vaccine, the patient experienced ongoing chills, fever, body soreness, runny nose,and headaches,awful feeling,feel weak,feels like a truck is sitting on top of me. No treatment medication was reported.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the events was considered to be unknown at the time of this report.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Erythema, Eye pain, Eye swelling
Clinical narrative: numbness/numbness in the back of neck; blurry vision/blurred vision/vision is so bad her eyes are almost shut; dizziness; couldn't walk; arm swelled way to elbow; pain at the back of her neck; swollen eye; red in the eye; pain in the eye; no energy; had a red spot on the same arm; tiredness; headaches; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness/numbness in the back of neck), VISION BLURRED (blurry vision/blurred vision/vision is so bad her eyes are almost shut), DIZZINESS (dizziness), MOBILITY DECREASED (couldn't walk) and SWELLING (arm swelled way to elbow) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no reported medical history). Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) and LORAZEPAM for COVID-19 vaccination.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness/numbness in the back of neck), VISION BLURRED (blurry vision/blurred vision/vision is so bad her eyes are almost shut), DIZZINESS (dizziness), MOBILITY DECREASED (couldn't walk), SWELLING (arm swelled way to elbow), NECK PAIN (pain at the back of her neck), EYE SWELLING (swollen eye), OCULAR HYPERAEMIA (red in the eye), EYE PAIN (pain in the eye), ASTHENIA (no energy), ERYTHEMA (had a red spot on the same arm), FATIGUE (tiredness) and HEADACHE (headaches). The patient was treated with PARACETAMOL (TYLENOL) for COVID-19 vaccination, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for COVID-19 vaccination, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (numbness/numbness in the back of neck), VISION BLURRED (blurry vision/blurred vision/vision is so bad her eyes are almost shut), DIZZINESS (dizziness), MOBILITY DECREASED (couldn't walk), SWELLING (arm swelled way to elbow), NECK PAIN (pain at the back of her neck), EYE SWELLING (swollen eye), OCULAR HYPERAEMIA (red in the eye), EYE PAIN (pain in the eye), ASTHENIA (no energy), ERYTHEMA (had a red spot on the same arm), FATIGUE (tiredness) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: No specific follow-up information recorded.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypoaesthesia, Mobility decreased, Neck pain
Clinical narrative: numbness/numbness in the back of neck; blurry vision/blurred vision/vision is so bad her eyes are almost shut; dizziness; couldn't walk; arm swelled way to elbow; pain at the back of her neck; swollen eye; red in the eye; pain in the eye; no energy; had a red spot on the same arm; tiredness; headaches; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness/numbness in the back of neck), VISION BLURRED (blurry vision/blurred vision/vision is so bad her eyes are almost shut), DIZZINESS (dizziness), MOBILITY DECREASED (couldn't walk) and SWELLING (arm swelled way to elbow) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no reported medical history). Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) and LORAZEPAM for COVID-19 vaccination.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness/numbness in the back of neck), VISION BLURRED (blurry vision/blurred vision/vision is so bad her eyes are almost shut), DIZZINESS (dizziness), MOBILITY DECREASED (couldn't walk), SWELLING (arm swelled way to elbow), NECK PAIN (pain at the back of her neck), EYE SWELLING (swollen eye), OCULAR HYPERAEMIA (red in the eye), EYE PAIN (pain in the eye), ASTHENIA (no energy), ERYTHEMA (had a red spot on the same arm), FATIGUE (tiredness) and HEADACHE (headaches). The patient was treated with PARACETAMOL (TYLENOL) for COVID-19 vaccination, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for COVID-19 vaccination, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (numbness/numbness in the back of neck), VISION BLURRED (blurry vision/blurred vision/vision is so bad her eyes are almost shut), DIZZINESS (dizziness), MOBILITY DECREASED (couldn't walk), SWELLING (arm swelled way to elbow), NECK PAIN (pain at the back of her neck), EYE SWELLING (swollen eye), OCULAR HYPERAEMIA (red in the eye), EYE PAIN (pain in the eye), ASTHENIA (no energy), ERYTHEMA (had a red spot on the same arm), FATIGUE (tiredness) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: No specific follow-up information recorded.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Ocular hyperaemia, Swelling, Vision blurred
Clinical narrative: numbness/numbness in the back of neck; blurry vision/blurred vision/vision is so bad her eyes are almost shut; dizziness; couldn't walk; arm swelled way to elbow; pain at the back of her neck; swollen eye; red in the eye; pain in the eye; no energy; had a red spot on the same arm; tiredness; headaches; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness/numbness in the back of neck), VISION BLURRED (blurry vision/blurred vision/vision is so bad her eyes are almost shut), DIZZINESS (dizziness), MOBILITY DECREASED (couldn't walk) and SWELLING (arm swelled way to elbow) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no reported medical history). Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) and LORAZEPAM for COVID-19 vaccination.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness/numbness in the back of neck), VISION BLURRED (blurry vision/blurred vision/vision is so bad her eyes are almost shut), DIZZINESS (dizziness), MOBILITY DECREASED (couldn't walk), SWELLING (arm swelled way to elbow), NECK PAIN (pain at the back of her neck), EYE SWELLING (swollen eye), OCULAR HYPERAEMIA (red in the eye), EYE PAIN (pain in the eye), ASTHENIA (no energy), ERYTHEMA (had a red spot on the same arm), FATIGUE (tiredness) and HEADACHE (headaches). The patient was treated with PARACETAMOL (TYLENOL) for COVID-19 vaccination, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for COVID-19 vaccination, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (numbness/numbness in the back of neck), VISION BLURRED (blurry vision/blurred vision/vision is so bad her eyes are almost shut), DIZZINESS (dizziness), MOBILITY DECREASED (couldn't walk), SWELLING (arm swelled way to elbow), NECK PAIN (pain at the back of her neck), EYE SWELLING (swollen eye), OCULAR HYPERAEMIA (red in the eye), EYE PAIN (pain in the eye), ASTHENIA (no energy), ERYTHEMA (had a red spot on the same arm), FATIGUE (tiredness) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: No specific follow-up information recorded.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Fatigue, Headache
Clinical narrative: unable to lift leg; pain in the back of the right knee; Chills; throbbing in the head; Fatigue; insatiable thirst; "no energy"; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of THIRST (insatiable thirst), ASTHENIA ("no energy"), LIMB DISCOMFORT (unable to lift leg), PAIN IN EXTREMITY (Sore arm) and ARTHRALGIA (pain in the back of the right knee) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 28-Feb-2021, the patient experienced THIRST (insatiable thirst), ASTHENIA ("no energy") and FATIGUE (Fatigue). On 02-Mar-2021, the patient experienced LIMB DISCOMFORT (unable to lift leg), ARTHRALGIA (pain in the back of the right knee), CHILLS (Chills) and HEADACHE (throbbing in the head). At the time of the report, THIRST (insatiable thirst), ASTHENIA ("no energy"), LIMB DISCOMFORT (unable to lift leg), PAIN IN EXTREMITY (Sore arm), ARTHRALGIA (pain in the back of the right knee), CHILLS (Chills), HEADACHE (throbbing in the head) and FATIGUE (Fatigue) outcome was unknown.            Reporter did not allow further contact
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity, Thirst
Clinical narrative: unable to lift leg; pain in the back of the right knee; Chills; throbbing in the head; Fatigue; insatiable thirst; "no energy"; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of THIRST (insatiable thirst), ASTHENIA ("no energy"), LIMB DISCOMFORT (unable to lift leg), PAIN IN EXTREMITY (Sore arm) and ARTHRALGIA (pain in the back of the right knee) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 28-Feb-2021, the patient experienced THIRST (insatiable thirst), ASTHENIA ("no energy") and FATIGUE (Fatigue). On 02-Mar-2021, the patient experienced LIMB DISCOMFORT (unable to lift leg), ARTHRALGIA (pain in the back of the right knee), CHILLS (Chills) and HEADACHE (throbbing in the head). At the time of the report, THIRST (insatiable thirst), ASTHENIA ("no energy"), LIMB DISCOMFORT (unable to lift leg), PAIN IN EXTREMITY (Sore arm), ARTHRALGIA (pain in the back of the right knee), CHILLS (Chills), HEADACHE (throbbing in the head) and FATIGUE (Fatigue) outcome was unknown.            Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Rash
Clinical narrative: Mosquito bite rash above waist on right; Rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Mosquito bite rash above waist on right) and INJECTION SITE RASH (Rash at injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced RASH (Mosquito bite rash above waist on right) and INJECTION SITE RASH (Rash at injection site). At the time of the report, RASH (Mosquito bite rash above waist on right) and INJECTION SITE RASH (Rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: fever of 101.5F; chills/shivering; Body aches; headache (felt like 3 trucks had collided and exploded); This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 101.5F), CHILLS (chills/shivering), MYALGIA (Body aches) and HEADACHE (headache (felt like 3 trucks had collided and exploded)) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (fever of 101.5F), CHILLS (chills/shivering), MYALGIA (Body aches) and HEADACHE (headache (felt like 3 trucks had collided and exploded)). At the time of the report, PYREXIA (fever of 101.5F), CHILLS (chills/shivering), MYALGIA (Body aches) and HEADACHE (headache (felt like 3 trucks had collided and exploded)) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Rash
Clinical narrative: Itchy and irritated at the injection site; Rash that is pinkish and not red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Itchy and irritated at the injection site) and RASH (Rash that is pinkish and not red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PRURITUS (Itchy and irritated at the injection site) and RASH (Rash that is pinkish and not red). At the time of the report, INJECTION SITE PRURITUS (Itchy and irritated at the injection site) and RASH (Rash that is pinkish and not red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chills, Feeling abnormal, Headache
Clinical narrative: slowed down; Tested positive; headache; muscle aches; body aches; chills; weakness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle aches), PAIN (body aches), CHILLS (chills), ASTHENIA (weakness) and FEELING ABNORMAL (slowed down) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced MYALGIA (muscle aches), PAIN (body aches), CHILLS (chills), ASTHENIA (weakness) and HEADACHE (headache). On 17-Feb-2021, the patient experienced FEELING ABNORMAL (slowed down) and COVID-19 (Tested positive). On 17-Feb-2021, MYALGIA (muscle aches), PAIN (body aches), CHILLS (chills), ASTHENIA (weakness) and HEADACHE (headache) had resolved. At the time of the report, FEELING ABNORMAL (slowed down) and COVID-19 (Tested positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, COVID-19: positive positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.